The fall in the market has marked TUBACEX’s results in the first quarter of 2021
Sales for the first quarter of the year amounted to €86.5M, down 43.7% on the same period for the previous year and the EBITDA stood at €0.1M. The low backlog for the first quarter of the year has led to low levels of activity in all of the Group’s divisions. The main...
TUBACEX presents results marked by COVID-19 and a drop in demand
TUBACEX ended the financial year with sales of 479.6 million euros, 21.8% less than the previous year and with EBITDA OF 38.1 million euros. Accumulated losses reached 25.3 million euros and derive mainly from negative results at the Basque production plants. The...
Podcast: NTS Group acquisition of Amega West – NTS CEO Paul McMillan talks to Pipeline Oil & Gas News
NTS Group CEO Paul McMillan talks to Julian Walker, Editor-in-Chief of Pipeline Oil & Gas, about the acquisition of Amega West Services. Click here to find out how the acquisition strengthens the NTS Group portfolio and how it was completed at such a challenging...
TUBACEX adapts its Organization to fight COVID-19: Q3 Results
TUBACEX’s sales figure for the first nine months of the year amounts to €389.6 million, which is 18.2% lower than that of the same period last year; while EBITDA stands at €26.4 million, down 42.9%, with a 6.8% margin. These results, determined by the global...
ARAMCO and local companies back COVID-19 aid initiatives in the Basque Country
The Energy Advanced Foundation, formed by TUBACEX, TUBOS REUNIDOS, AMPO and VICINAY MARINE will direct the implementation of the program. The Red Cross, Caritas, Biocruces Bizkaia Health Research Institute, the start-up Eversens, and food banks across Álava, Biscay...
The 50% fall in the market and COVID-19 mark TUBACEX’s results
The sales figure for the first half of the year amounts to €282 M, down 12.8% on the same period last year, and the EBITDA stands at €19.8 M, 40.5% less. These figures are a far cry from TUBACEX’s prospects at the start of the year but, even in such an unfavorable...
The global restructuring of the Tubacex Group will affect 20% of the workforce
The negative evolution of the market over the last few years, with a drop of over 50%, and the coronavirus crisis have prompted the Company to implement a series of urgent industrial reorganization and cost-cutting measures. Specifically, with regards to employment,...
TUBACEX holds its Annual Shareholders’ General Meeting overshadowed by COVID-19
The company reveals the main points of its strategy in response to the pandemic. With a focus on prevention, the aim is to guarantee the safety of all its workers, and thereby service continuity for its customers. TUBACEX has dealt with this crisis from a solid...
TUBACEX presents its results in a market context dominated by COVID-19
2019 has marked a turning point for recovery as TUBACEX order intake demonstrates. Although far from pre-crisis levels it has experienced an increase of 30% in relation to the previous year. This gradual and general market recovery is also enabling operating leverage ratios to be maintained for all business units and therefore, achieving double-digit consolidated margins.
TUBACEX announces consolidated results and ends 2019 with an EBITDA of €67.1 million
2019 has marked a turning point for recovery as TUBACEX order intake demonstrates. Although far from pre-crisis levels it has experienced an increase of 30% in relation to the previous year. This gradual and general market recovery is also enabling operating leverage ratios to be maintained for all business units and therefore, achieving double-digit consolidated margins.
WORLDWIDE
PRESENCE
AVOID
FALSIFICATIONS
